Which hedge funds own LXRX? LEXICON PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in LXRX (LEXICON PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $29.1m in total. The largest holder by portfolio weight is Point72 Asset Management LP at 0.0% of its book. 1 manager opened a new position this quarter: D. E. Shaw & Co. 2 exited: Brevan Howard Capital Management, Marshall Wace.
5tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold LXRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Point72 Asset Management LP | Q2 2026 | 0.0% | $19.8m | 8,251,325 | 6% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.7m | 1,127,000 | -30% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $3.8m | 1,601,182 | 46% | added |
| Millennium Management | Q2 2026 | 0.0% | $2.7m | 1,134,229 | -77% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $53.3k | 22,200 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $250.4k |
| Marshall Wace | 0.1% | $3.7m |
How has hedge fund ownership of LXRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $29.1m |
| Q1 2026 | 6 | $28.1m |
| Q4 2025 | 2 | $629.4k |
| Q3 2025 | 1 | $394.7k |
| Q4 2024 | 3 | $6.8m |
| Q3 2024 | 2 | $3.8m |
| Q2 2024 | 2 | $7.0m |
| Q1 2024 | 1 | $1.4m |
| Q4 2023 | 2 | $703.1k |
| Q3 2023 | 2 | $348.3k |
| Q2 2023 | 1 | $111.3k |
| Q1 2023 | 3 | $1.9m |
| Q4 2022 | 3 | $3.4m |
| Q3 2022 | 3 | $10.0m |
| Q2 2022 | 1 | $195.0k |
| Q1 2022 | 2 | $478.0k |
Counts every tracked manager that disclosed LXRX in that quarter's filing, including managers that have since stopped filing.